Hypoglycemia Management and Workup
Acute Treatment Protocol
For conscious patients with hypoglycemia (blood glucose ≤70 mg/dL), immediately administer 15-20 grams of oral glucose, recheck blood glucose at 15 minutes, and repeat treatment if hypoglycemia persists. 1, 2
Immediate Treatment Steps
- Administer 15-20g of pure glucose orally as first-line treatment for any conscious patient with blood glucose ≤70 mg/dL 3, 1, 2
- Pure glucose (tablets or solution) is preferred because the glycemic response correlates better with glucose content than total carbohydrate content 3, 1
- Any carbohydrate-containing food with glucose can be used if pure glucose is unavailable, though glucose tablets/solution are most effective 3, 1
Monitoring and Repeat Treatment
- Recheck blood glucose 15 minutes after initial treatment 3, 1, 4
- If hypoglycemia persists at 15 minutes, immediately repeat another 15-20g of glucose 1, 4
- Initial response should occur within 10-20 minutes 3, 4
- Recheck blood glucose again at 60 minutes after initial treatment, as additional intervention may be necessary 3, 1
- Once blood glucose normalizes, have the patient consume a meal or snack with complex carbohydrates and protein to prevent recurrence 3, 2
Special Dosing Considerations
- For patients using automated insulin delivery systems, a lower dose of 5-10g carbohydrates may be appropriate, unless hypoglycemia occurs with exercise or after significant insulin overestimation 1, 2
- For critically ill patients, administer 10-20g of hypertonic (50%) dextrose intravenously, titrated based on initial glucose value 4
Severe Hypoglycemia (Unconscious or Unable to Take Oral Treatment)
For unconscious patients or those unable to take oral carbohydrates, immediately administer glucagon via injection or intranasal route. 1, 2
- Glucagon is indicated for any patient unable or unwilling to consume oral carbohydrates 3, 1
- Newer intranasal and ready-to-inject glucagon preparations are preferred due to ease of administration 1
- Dosing: 1 mg (1 mL) subcutaneously or intramuscularly for adults and children ≥25 kg or ≥6 years; 0.5 mg (0.5 mL) for children <25 kg or <6 years 1
- All individuals at high risk of hypoglycemia should be prescribed glucagon 2
- Family members and caregivers must be instructed on glucagon administration, including where it is kept and when/how to administer it 1
Critical Treatment Pitfalls to Avoid
- Never delay treatment while waiting for laboratory confirmation of blood glucose, though document glucose before treatment whenever possible 1, 4
- Do not use protein to treat acute hypoglycemia as it may increase insulin secretion without raising plasma glucose, particularly in type 2 diabetes 1, 2, 4
- Avoid adding fat to carbohydrate treatment as it may slow and prolong the acute glycemic response 3, 1
- Do not assume resolution after one treatment; always recheck at 15 minutes 4
- Orange juice and glucose gel are less effective than glucose tablets or solution 1
Subsequent Workup and Management
Immediate Post-Event Assessment
Any episode of severe hypoglycemia (requiring assistance) or blood glucose <54 mg/dL mandates immediate reevaluation and review of the treatment regimen. 1
- Document the circumstances: timing, recent food intake, physical activity, medication doses and timing 3
- Assess for medication-related causes, particularly insulin secretagogues (sulfonylureas, meglitinides) 1, 2
- Evaluate for alcohol consumption, which inhibits gluconeogenesis 2, 4, 5
- Consider prolonged fasting or delayed/skipped meals 2, 4
Medication-Specific Considerations
- Sulfonylurea-induced hypoglycemia requires prolonged observation (24-48 hours) due to long half-life and may need continuous dextrose infusion 4
- Consider octreotide for refractory sulfonylurea toxicity 4
- Metformin alone carries minimal hypoglycemia risk 1
- Strongly discourage sliding scale insulin use 1
Risk Stratification for Recurrent Episodes
- Patients with recurrent hypoglycemia despite appropriate treatment require hospital admission 4
- Consider admission for any severe hypoglycemia episode or unexplained recurrent mild-to-moderate episodes 1
- Admit patients with underlying infection, hepatic failure, or renal failure, as these conditions impair gluconeogenesis 4
Long-Term Management Adjustments
- For patients with hypoglycemia unawareness, raise glycemic targets to strictly avoid hypoglycemia for at least several weeks to partially reverse the condition 1
- Consider deintensifying or switching diabetes medications when risks exceed benefits 1
- For recurrent hypoglycemia, consider continuous glucose monitoring 2
- Implement consistent meal timing when on fixed insulin regimens 2
Patient and Caregiver Education
- Teach recognition of hypoglycemia symptoms (sweating, tremor, palpitations, hunger, confusion, weakness) 5
- Instruct patients to always carry fast-acting glucose sources 1, 2
- Educate on high-risk situations: fasting for procedures, delayed meals, intense exercise, alcohol consumption, sleep, declining renal function 1
- Ensure patients understand that blood glucose 60-80 mg/dL may require carbohydrate ingestion 1
Resistant Hypoglycemia (Fails Initial Treatment)
Resistant hypoglycemia occurs in approximately 30% of hypoglycemic patients presenting to emergency departments and requires escalated management. 4
Causes of Resistant Hypoglycemia
- Insulin secretagogues (sulfonylureas) are the most common cause due to prolonged duration of action 4
- Hepatic failure reduces gluconeogenesis, preventing adequate glucose production 4
- Renal impairment decreases insulin clearance and impairs gluconeogenesis 4
- Alcohol inhibits gluconeogenesis and causes prolonged hypoglycemia 4, 5
- Prolonged fasting depletes glycogen stores 4
- Post-bariatric surgery patients develop altered gut hormone responses 2, 4
Escalated Management
- Start continuous dextrose-containing IV fluids to prevent recurrence 4
- Continue monitoring every 30-60 minutes until stable for at least 2 hours 4
- For alcohol-related hypoglycemia, administer thiamine before glucose in chronic alcoholics to prevent Wernicke's encephalopathy 4
- Consider ICU admission for patients requiring continuous insulin infusion protocols or frequent glucose monitoring 4